Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INTERFERON BETA-1A Cause Gallbladder disorder? 107 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 107 reports of Gallbladder disorder have been filed in association with INTERFERON BETA-1A (Avonex). This represents 0.2% of all adverse event reports for INTERFERON BETA-1A.

107
Reports of Gallbladder disorder with INTERFERON BETA-1A
0.2%
of all INTERFERON BETA-1A reports
1
Deaths
57
Hospitalizations

How Dangerous Is Gallbladder disorder From INTERFERON BETA-1A?

Of the 107 reports, 1 (0.9%) resulted in death, 57 (53.3%) required hospitalization, and 1 (0.9%) were considered life-threatening.

Is Gallbladder disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1A. However, 107 reports have been filed with the FAERS database.

What Other Side Effects Does INTERFERON BETA-1A Cause?

Multiple sclerosis relapse (5,931) Influenza like illness (4,475) Memory impairment (3,468) Multiple sclerosis (3,412) Fatigue (3,164) Fall (3,128) Gait disturbance (3,031) Death (2,766) Pain (2,692) Headache (2,533)

What Other Drugs Cause Gallbladder disorder?

ADALIMUMAB (754) LENALIDOMIDE (643) ETANERCEPT (303) YAZ (241) YASMIN (211) ABATACEPT (203) RITUXIMAB (184) METHOTREXATE (183) TOFACITINIB (167) TIRZEPATIDE (163)

Which INTERFERON BETA-1A Alternatives Have Lower Gallbladder disorder Risk?

INTERFERON BETA-1A vs INTERFERON BETA-1B INTERFERON BETA-1A vs INTERFERON GAMMA INTERFERON BETA-1A vs INTERFERON GAMMA-1B INTERFERON BETA-1A vs INVEGA INTERFERON BETA-1A vs INVEGA SUSTENNA

Related Pages

INTERFERON BETA-1A Full Profile All Gallbladder disorder Reports All Drugs Causing Gallbladder disorder INTERFERON BETA-1A Demographics